Insights

Rising to the challenge: diagnosing, treating and managing respiratory infections using rapid PCR testing at the Point of Care. NEWCASTLE UPON TYNE, UK, 5 July 2022. QuantuMDx Group Limited (“QuantuMDx”) will be offering insights and advice on tackling respiratory infections…

NEWCASTLE UPON TYNE, UK, [17 June 2022. QuantuMDx Group Limited (“QuantuMDx”), a UK-based developer of…

NEWCASTLE UPON TYNE, UK, 14 June 2022. QuantuMDx Group Limited (“QuantuMDx”), a UK-based developer of…

NEWCASTLE UPON TYNE, UK, [9] June 2022. QuantuMDx Group Limited (“QuantuMDx”), a UK-based developer of transformational point-of-care diagnostics, is pleased to announce that it has won the Special Recognition Award (Response to Covid-19)] at the Med-Tech Innovation Awards 2022. QuantuMDx…